Cart
sales@molnova.com
KPLH1130
KPLH1130
Catalog No. M24944
KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 217 | In Stock |
|
| 10MG | 351 | In Stock |
|
| 25MG | 591 | In Stock |
|
| 50MG | 823 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2260 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKPLH1130
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1.Min BK, et al. Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype. Front Immunol. 2019 May 7;10:944.
molnova catalog
related products
-
OSU-03013
OSU-03013 (OSU 03013, OSU03013) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 2 uM.
-
6-Bromo-4-methoxypyr...
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
-
BX-320
BX-320 is a potent, selective and ATP-competitive inhibitor of PDK1 with IC50 of 30 nM.
